Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12605366 | Telmisartan for the treatment of hypertension in dogs | 🖼🧊📄§ | 2026-04-21 | 2040-04-30 | 0 | 31 |
| 12605446 | PSMA-targeted immunotherapies for cancers | 🖼🧊📄§ | 2026-04-21 | 2041-08-20 | 0 | 31 |
| 12605367 | Methods of treatment and/or prevention of disorders and symptoms related to BKCa and/or SK channelophathies | 🖼🧊📄§ | 2026-04-21 | 2040-09-15 | 0 | 31 |
| 12605414 | Discovery of novel Akkermansia muciniphila AK32 and application thereof for improving intestinal function | 🖼🧊📄§ | 2026-04-21 | 2041-05-07 | 0 | 31 |
| 12606598 | Chimeric klebicins | 🖼🧊📄§ | 2026-04-21 | 2042-07-08 | 0 | 31 |
| 12605332 | Transdermal delivery formulations | 🖼🧊📄§ | 2026-04-21 | 2042-10-31 | 0 | 31 |
| 12606796 | Delivery of oncolytic viruses using dendritic cells | 🖼🧊📄§ | 2026-04-21 | 2040-05-07 | 0 | 31 |
| 12605343 | Method for producing microbubble-containing electrolyte solution and method for producing microbubble-containing solvent used for preparing microbubble-containing electrolyte solution | 🖼🧊📄§ | 2026-04-21 | 2040-08-24 | 0 | 31 |
| 12605411 | Phospholipid compositions for delivery of therapeutic compounds | 🖼🧊📄§ | 2026-04-21 | 2044-06-05 | 0 | 31 |
| 12605415 | Compositions and methods | 🖼🧊📄§ | 2026-04-21 | 2043-07-11 | 0 | 31 |
| 12605412 | Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments | 🖼🧊📄§ | 2026-04-21 | 2040-09-29 | 0 | 31 |
| 12605355 | HA-paclitaxel conjugate for treatment of mesothelioma | 🖼🧊📄§ | 2026-04-21 | 2041-04-07 | 0 | 31 |
| 12606528 | Methods and materials for inhibiting NF-kB activity | 🖼🧊📄§ | 2026-04-21 | 2040-11-20 | 0 | 31 |
| 12605448 | Porous self-healing polymer matrix for encapsulation of active macromolecules and methods | 🖼🧊📄§ | 2026-04-21 | 2040-07-20 | 0 | 31 |
| 12605449 | Drug-clay mineral complex containing phospholipid and oral administration composition including same | 🖼🧊📄§ | 2026-04-21 | 2041-07-01 | 0 | 31 |
| 12606801 | Herpesvirus with modified glycoprotein H for propagation in a cell | 🖼🧊📄§ | 2026-04-21 | 2037-06-08 | 0 | 31 |
| 12606831 | Method for producing t cells modified by chimeric antigen receptor | 🖼🧊📄§ | 2026-04-21 | 2039-01-18 | 0 | 31 |
| 12606578 | Crystal form of spirocyclic amine aryl phosphorus oxide compound and preparation method therefor | 🖼🧊📄§ | 2026-04-21 | 2043-07-28 | 0 | 31 |
| 12606570 | Deuterated compounds and imaging agents for imaging huntingtin protein | 🖼🧊📄§ | 2026-04-21 | 2042-04-26 | 0 | 31 |
| 12606594 | Heterotandem bicyclic peptide complexes | 🖼🧊📄§ | 2026-04-21 | 2042-02-02 | 0 | 31 |
| 12606596 | Self-assembling insect ferritin nanoparticles | 🖼🧊📄§ | 2026-04-21 | 2044-03-25 | 0 | 31 |
| 12606610 | Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes | 🖼🧊📄§ | 2026-04-21 | 2043-08-16 | 0 | 31 |
| 12606609 | Polypeptides having improved properties | 🖼🧊📄§ | 2026-04-21 | 2041-01-26 | 0 | 31 |
| 12606606 | Nucleic acid construct that encodes chimeric rhodopsin | 🖼🧊📄§ | 2026-04-21 | 2040-09-11 | 0 | 31 |
| 12606617 | Composition comprising an IgE antibody | 🖼🧊📄§ | 2026-04-21 | 2041-04-23 | 0 | 31 |
| 12606616 | PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer | 🖼🧊📄§ | 2026-04-21 | 2045-12-08 | 0 | 31 |
| 12606633 | Methods and compositions for anti-CD73 antibodies and variants | 🖼🧊📄§ | 2026-04-21 | 2042-01-25 | 0 | 31 |
| 12606634 | Antibody-pyrrolobenzodiazepine derivative conjugate which binds caludin-6 and claudin-9 | 🖼🧊📄§ | 2026-04-21 | 2044-04-08 | 0 | 31 |
| 12606632 | Anti-CD40 antibodies and methods of use | 🖼🧊📄§ | 2026-04-21 | 2043-03-13 | 0 | 31 |
| 12606638 | Dosing regimens for use with PCSK9 inhibitors | 🖼🧊📄§ | 2026-04-21 | 2043-04-17 | 0 | 31 |
| 12606641 | Amphiphilic carbohydrate compounds | 🖼🧊📄§ | 2026-04-21 | 2041-05-21 | 0 | 31 |
| 12606805 | Tymovirus virus and virus-like particles as nanocarriers for imaging and therapeutic agents | 🖼🧊📄§ | 2026-04-21 | 2043-08-29 | 0 | 31 |
| 12606804 | Influenza virus backbone | 🖼🧊📄§ | 2026-04-21 | 2041-07-21 | 0 | 31 |
| 12606833 | Modified mini-nucleosome core proteins and use in nucleic acid delivery | 🖼🧊📄§ | 2026-04-21 | 2041-04-12 | 0 | 31 |
| 12606571 | Macrocyclic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-04-09 | 0 | 31 |
| 12606639 | Antigen binding proteins | 🖼🧊📄§ | 2026-04-21 | 2045-05-20 | 0 | 31 |
| 12606535 | Gas phase methods to extract natural products | 🖼🧊📄§ | 2026-04-21 | 2041-02-08 | 0 | 31 |
| 12606827 | Compounds for treatment of osteoarthritis | 🖼🧊📄§ | 2026-04-21 | 2043-05-19 | 0 | 31 |
| 12606620 | Anti-LILRB1 antibody and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2041-07-27 | 0 | 31 |
| 12599638 | Feed and composition comprising lactic acid bacteria and fatty acid | 🖼🧊📄§ | 2026-04-14 | 2041-09-21 | 0 | 31 |
| 12600783 | Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2040-07-02 | 0 | 31 |
| 12600724 | Indole alkaloid and preparation method and use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-11-09 | 0 | 31 |
| 12600766 | Anti-TDP-43 binding molecules and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-05-22 | 0 | 31 |
| 12600779 | LAG-3-binding molecules and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2043-11-21 | 0 | 31 |
| 12600973 | CpG ODN having immunoregulatory function and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-31 | 0 | 31 |
| 12600955 | Replication-competent recombinant herpes simplex virus type 1 (HSV-1) comprising deletions in the ICP6 and IR regions | 🖼🧊📄§ | 2026-04-14 | 2039-08-09 | 0 | 31 |
| 12600793 | Chimeric antigen receptors with MAGE-A4 specificity and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-07-24 | 0 | 31 |
| 12600757 | Peptides inhibiting gamma-c-cytokine activity and methods of use | 🖼🧊📄§ | 2026-04-14 | 2038-04-04 | 0 | 31 |
| 12600945 | Human Vγ9Vδ2T cell proliferation culture method and culture medium | 🖼🧊📄§ | 2026-04-14 | 2039-02-19 | 0 | 31 |
| 12599628 | Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions | 🖼🧊📄§ | 2026-04-14 | 2045-05-28 | 0 | 31 |